Jamie Michele Jacobs

Jamie Michele Jacobs

Auto-generated profile, based on publicly available information

Jamie Michele Jacobs

Mass General Brigham Cancer Institute, Boston, MA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2016 in Cancer
Verified
Journal Article
Open access
PDF file
RNRyan Nipp
Ryan Nipp
AEAreej El‐Jawahri
Areej El‐Jawahri
JFJoel N. Fishbein
Joel N. Fishbein
JEJustin Eusebio
Justin Eusebio
JSJamie M. Stagl
Jamie M. Stagl
JTJennifer S. Temel
Jennifer S. Temel
BACKGROUND: Patients with incurable cancer face many physical and emotional stressors, yet little is known about their coping strategies or the relationship between their coping strategies, quality of life (QOL), and mood.METHODS: As part of a randomized trial of palliative care, this study assessed baseline QOL (Functional Assessment of Cancer Therapy–General), mood (Hospital Anxiety and Depression Scale), and coping (Brief COPE) in patients within 8 weeks of a diagnosis of incurable lung or gastrointestinal cancer and before randomization. To examine associations between coping strategies, QOL, and mood, we used linear regression, adjusting for patients' age, sex, marital status, and cancer type.RESULTS: There were 350 participants (mean age, 64.9 years), and the majority were male (54.0%), were married (70.0%), and had lung cancer (54.6%). Most reported high utilization of emotional support coping (77.0%), whereas fewer reported high utilization of acceptance (44.8%), self‐blame (37.9%), and denial (28.2%). Emotional support (QOL: β = 2.65, P < .01; depression: β = –0.56, P = .02) and acceptance (QOL: β = 1.55, P < .01; depression: β = –0.37, P = .01; anxiety: β = –0.34, P = .02) correlated with better QOL and mood. Denial (QOL: β = –1.97, P < .01; depression: β = 0.36, P = .01; anxiety: β = 0.61, P < .01) and self‐blame (QOL: β = –2.31, P < .01; depression: β = 0.58, P < .01; anxiety: β = 0.66, P < .01) correlated with worse QOL and mood.CONCLUSIONS: Patients with newly diagnosed, incurable cancer use a variety of coping strategies. The use of emotional support and acceptance coping strategies correlated with better QOL and mood, whereas the use of denial and self‐blame negatively correlated with these outcomes. Interventions to improve patients' QOL and mood should seek to cultivate the use of adaptive coping strategies. Cancer 2016;122:2110–6. © 2016 American Cancer Society.

23 March 2015 in Cancer
Verified
Journal Article
Open access
PDF file
JSJamie M. Stagl
Jamie M. Stagl
LBLaura C. Bouchard
Laura C. Bouchard
SLSuzanne C. Lechner
Suzanne C. Lechner
BBBonnie B. Blomberg
Bonnie B. Blomberg
LGLisa M. Gudenkauf
Lisa M. Gudenkauf
MAMichael H. Antoni
Michael H. Antoni
BACKGROUND: Breast cancer survivors experience long‐term physical and psychological sequelae after their primary treatment that negatively influence their quality of life (QOL) and increase depressive symptoms. Group‐based cognitive‐behavioral stress management (CBSM) delivered after surgery for early‐stage breast cancer was previously associated with better QOL over a 12‐month follow‐up and with fewer depressive symptoms up to 5 years after study enrollment. This 8‐ to 15‐year follow‐up (median, 11 years) of a previously conducted trial (NCT01422551) evaluated whether women in this cohort receiving CBSM had fewer depressive symptoms and better QOL than controls at an 8‐ to 15‐year follow‐up.METHODS: Women with stage 0 to IIIb breast cancer were initially recruited 2 to 10 weeks after surgery and randomized to a 10‐week CBSM intervention or a 1‐day psychoeducational control group. One hundred women (51 CBSM patients and 49 controls) were recontacted 8 to 15 years after study enrollment to participate in a follow‐up assessment. The Center for Epidemiologic Studies–Depression (CES‐D) scale and the Functional Assessment of Cancer Therapy–Breast (FACT‐B) were self‐administered. Multiple regression was employed to evaluate group differences on the CES‐D scale and FACT‐B over and above effects of confounding variables.RESULTS: Participants assigned to CBSM reported significantly lower depressive symptoms (d, 0.63; 95% confidence interval [CI], 0.56‐0.70) and better QOL (d, 0.58; 95% CI, 0.52‐0.65) above the effects of the covariates.CONCLUSIONS: Women who received CBSM after surgery for early‐stage breast cancer reported lower depressive symptoms and better QOL than the control group up to 15 years later. Early implementation of cognitive‐behavioral interventions may influence long‐term psychosocial functioning in breast cancer survivors. Cancer 2015;121:1873–1881. © 2015 American Cancer Society.

11 March 2019 in Journal of the National Comprehensive Cancer Network
Verified
Journal Article
Open access
PDF file
JJJamie M. Jacobs
Jamie M. Jacobs
MRMolly E. Ream
Molly E. Ream
NPNicole Pensak
Nicole Pensak
LNLauren E. Nisotel
Lauren E. Nisotel
JFJoel N. Fishbein
Joel N. Fishbein
JGJoseph A. Greer
Joseph A. Greer
Background:Oral therapies are increasingly common in oncology care. However, data are lacking regarding the physical and psychologic symptoms patients experience, or how these factors relate to medication adherence and quality of life (QoL).Materials and Methods:From December 2014 through August 2016, a total of 181 adult patients who were prescribed oral targeted therapy or chemotherapy enrolled in a randomized study of adherence and symptom management at Massachusetts General Hospital Cancer Center. Patients completed baseline assessments of adherence with electronic pill cap, QoL, symptom severity, mood, social support, fatigue, and satisfaction with clinicians and treatment. Relationships among these factors were examined using Pearson product-moment correlations and multivariable linear regression.Results:At baseline, the mean electronic pill cap adherence rate showed that patients took 85.57% of their oral therapy. The most commonly reported cancer-related symptoms were fatigue (88.60%), drowsiness (76.50%), disturbed sleep (68.20%), memory problems (63.10%), and emotional distress (60.80%). Patients who reported greater cancer-related symptom severity had lower adherence (r= −0.20). In a multivariable regression, greater depressive and anxiety symptoms, worse fatigue, less social support, lower satisfaction with clinicians and treatment, and higher symptom burden were associated with worse QoL (F[10, 146]=50.53; adjustedR2=0.77). Anxiety symptoms were most strongly associated with clinically meaningful decrements in QoL (β= −7.10; SE=0.22).Conclusions:Patients prescribed oral therapies struggle with adherence, and cancer-related symptom burden is high and related to worse adherence and QoL. Given perceptions that oral therapies are less impairing, these data underscore the strong need to address adherence issues, symptom burden, and QoL for these patients.

30 October 2015 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
JSJamie M. Stagl
Jamie M. Stagl
SLSuzanne C. Lechner
Suzanne C. Lechner
CCCharles S. Carver
Charles S. Carver
LBLaura C. Bouchard
Laura C. Bouchard
LGLisa M. Gudenkauf
Lisa M. Gudenkauf
MAMichael H. Antoni
Michael H. Antoni

17 January 2017 in Annals of Behavioral Medicine
Verified
Journal Article
Open access
PDF file
JJJamie M. Jacobs
Jamie M. Jacobs
KSKelly M. Shaffer
Kelly M. Shaffer
RNRyan D. Nipp
Ryan D. Nipp
JFJoel N. Fishbein
Joel N. Fishbein
JMJames MacDonald
James MacDonald
JGJoseph A. Greer
Joseph A. Greer
Background. Individuals with advanced, incurable cancer often experience high physical and psychological symptom burden. Family and friend caregivers ar

1 August 2015 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Open access
LGLisa M. Gudenkauf
Lisa M. Gudenkauf
MAMichael H. Antoni
Michael H. Antoni
JSJamie M. Stagl
Jamie M. Stagl
SLSuzanne C. Lechner
Suzanne C. Lechner
DJDevika R. Jutagir
Devika R. Jutagir
CCCharles S. Carver
Charles S. Carver
Women with breast cancer (BCa) report elevated distress postsurgery. Group-based cognitive-behavioral stress management (CBSM) following surgery improves psychological adaptation, though its key mechanisms remain speculative. This randomized controlled dismantling trial compared 2 interventions featuring elements thought to drive CBSM effects: a 5-week cognitive-behavioral training (CBT) and 5-week relaxation training (RT) versus a 5-week health education (HE) control group. Women with stage 0-III BCa (N = 183) were randomized to CBT, RT, or HE condition 2-10 weeks postsurgery. Psychosocial measures were collected at baseline (T1) and postintervention (T2). Repeated-measures analyses of variance (ANOVAs) tested whether CBT and RT treatments improved primary measures of psychological adaptation and secondary measures of stress management resource perceptions from pre- to postintervention relative to HE. Both CBT and RT groups reported reduced depressive affect. The CBT group reported improved emotional well-being/quality of life and less cancer-specific thought intrusions. The RT group reported improvements on illness-related social disruption. Regarding stress management resources, the CBT group reported increased reliability of social support networks, while the RT group reported increased confidence in relaxation skills. Psychological adaptation and stress management resource constructs were unchanged in the HE control group. Nonmetastatic breast cancer patients participating in 2 forms of brief, 5-week group-based stress management intervention after surgery showed improvements in psychological adaptation and stress management resources compared with an attention-matched control group. Findings provide preliminary support suggesting that using brief group-based stress management interventions may promote adaptation among nonmetastatic breast cancer patients.